Exact peptide identities attached to retained registry observations carrying this condition label.
Coverage-gated living condition brief
Prostate Cancer peptide evidence brief
A cited Prostate Cancer peptide evidence brief across 57 exact-label ClinicalTrials.gov records, 6 connected profiles, and 16 registry-update years. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
57 selected records.
6 profiles.
2010–2026 in selected records.
Direct collection answer · published August 17, 2026
What peptide evidence does PeptideScanner carry for Prostate Cancer?
PeptideScanner’s selected collection contains 57 retained ClinicalTrials.gov records carrying the exact condition label “Prostate Cancer,” connected to 6 peptide profiles across 16 registry-update years.
That answer describes this collection and the exact cited registry observations below. It is not a conclusion about whether any peptide treats Prostate Cancer, and it is not a safety or efficacy assessment.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 277 selected PubMed records and 38 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Prostate Cancer unless their own cited source says so.
Related profile context
Literature connected through these peptide profiles
This is a bounded sample of up to six PubMed bibliography records connected through peptide profiles on this hub, not the total profile literature count above. They are not condition-matched records, and their presence does not establish that they concern Prostate Cancer.
Degarelix · source record 2026-11-17
Development and Validation of a Stability-Indicating HPLC Method for Degarelix and Characterization of Its Degradation Impurities Using LC-MS, 1H NMR, and FTIR Techniques.
PubMed lists PMID 43041099 in Biomedical chromatography : BMC as Journal Article, with publication-date metadata of 2027-01 (month precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Leuprolide · source record 2026-11-06
Leuprolide acetate, a GnRH agonist, preserves cerebellar integrity and motor coordination in a rat model of hepatic encephalopathy.
PubMed lists PMID 42962871 in Physiology & behavior as Journal Article, with publication-date metadata of 2026-10-30 (day precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Goserelin · source record 2026-08-13
Roles of Goserelin in Gynecological Disorders.
PubMed lists PMID 42226753 in Drug design, development and therapy as Journal Article, Review, with publication-date metadata of 2026-05-27 (day precision). PeptideScanner associated the retained record with the identity slug goserelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Triptorelin · source record 2026-11-09
Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial.
PubMed lists PMID 25990480 in Archives of gynecology and obstetrics as Clinical Trial, Comparative Study, Journal Article, with publication-date metadata of 2015-05-20 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Pasireotide · source record 2026-10-31
Pasireotide-LAR and pegvisomant combination in resistant acromegaly: a case series of predominantly mammosomatotroph adenomas.
PubMed lists PMID 42778805 in Pituitary as Journal Article, with publication-date metadata of 2026-09-23 (day precision). PeptideScanner associated the retained record with the identity slug pasireotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Semaglutide · source record 2026-11-12
Semaglutide and alcohol use disorder: An evidence gap India must fill.
PubMed lists PMID 43011941 in Indian journal of psychiatry as Letter, with publication-date metadata of 2026-10-21 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT00003026
PeptideScanner retained ClinicalTrials.gov record NCT00003026 at 2026-11-15T21:49:16.513Z. Its registry update date was 2012-07-02, and PeptideScanner's reviewed identity mapping was triptorelin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- July 2, 2012
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00004124
PeptideScanner retained ClinicalTrials.gov record NCT00004124 at 2026-11-15T21:50:32.222Z. Its registry update date was 2022-12-30, and PeptideScanner's reviewed identity mapping was goserelin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- December 30, 2022
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00005044
PeptideScanner retained ClinicalTrials.gov record NCT00005044 at 2026-11-15T21:50:32.222Z. Its registry update date was 2022-06-15, and PeptideScanner's reviewed identity mapping was goserelin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- June 15, 2022
- Evidence lane
- Clinical trials
Exact-record source chronology
Prostate Cancer registry timeline
Years come from the last-update date on each retained ClinicalTrials.gov observation. They show source chronology, not when PeptideScanner added the record and not a continuous monitoring guarantee.
2026
8 recordsLeuprolide · 2026-11-02
ClinicalTrials.gov record NCT07848828
Recruiting at the retained observation.
Open cited registry record →Degarelix · 2026-10-15
ClinicalTrials.gov record NCT03689699
Completed at the retained observation.
Open cited registry record →Semaglutide · 2026-09-14
ClinicalTrials.gov record NCT06908694
Active, not recruiting at the retained observation.
Open cited registry record →Leuprolide · 2026-09-03
ClinicalTrials.gov record NCT07801664
Recruiting at the retained observation.
Open cited registry record →Leuprolide · 2026-08-06
ClinicalTrials.gov record NCT07455903
Recruiting at the retained observation.
Open cited registry record →Leuprolide · 2026-07-30
ClinicalTrials.gov record NCT05765500
Recruiting at the retained observation.
Open cited registry record →Leuprolide · 2026-07-10
ClinicalTrials.gov record NCT05498272
Active, not recruiting at the retained observation.
Open cited registry record →Leuprolide · 2026-07-09
ClinicalTrials.gov record NCT02319837
Active, not recruiting at the retained observation.
Open cited registry record →2025
5 recordsDegarelix · 2025-12-18
ClinicalTrials.gov record NCT00117286
Completed at the retained observation.
Open cited registry record →Goserelin · 2025-07-16
ClinicalTrials.gov record NCT02430480
Completed at the retained observation.
Open cited registry record →Triptorelin · 2025-06-05
ClinicalTrials.gov record NCT00667069
Completed at the retained observation.
Open cited registry record →Goserelin · 2025-05-16
ClinicalTrials.gov record NCT00328614
Completed at the retained observation.
Open cited registry record →Degarelix · 2025-04-13
ClinicalTrials.gov record NCT01220869
Completed at the retained observation.
Open cited registry record →2024
3 recordsPasireotide · 2024-10-01
ClinicalTrials.gov record NCT01794793
Completed at the retained observation.
Open cited registry record →Degarelix · 2024-09-27
ClinicalTrials.gov record NCT05181800
Completed at the retained observation.
Open cited registry record →Triptorelin · 2024-06-25
ClinicalTrials.gov record NCT06473259
Recruiting at the retained observation.
Open cited registry record →2023
3 recordsDegarelix · 2023-11-30
ClinicalTrials.gov record NCT00818623
Completed at the retained observation.
Open cited registry record →Degarelix · 2023-11-30
ClinicalTrials.gov record NCT00819156
Completed at the retained observation.
Open cited registry record →Degarelix · 2023-11-09
ClinicalTrials.gov record NCT00819247
Completed at the retained observation.
Open cited registry record →2022
2 recordsGoserelin · 2022-12-30
ClinicalTrials.gov record NCT00004124
Completed at the retained observation.
Open cited registry record →Goserelin · 2022-06-15
ClinicalTrials.gov record NCT00005044
Completed at the retained observation.
Open cited registry record →2021
2 recordsDegarelix · 2021-11-19
ClinicalTrials.gov record NCT01751451
Completed at the retained observation.
Open cited registry record →Triptorelin · 2021-02-21
ClinicalTrials.gov record NCT00104741
Completed at the retained observation.
Open cited registry record →2019
2 recordsTriptorelin · 2019-07-25
ClinicalTrials.gov record NCT02238366
Completed at the retained observation.
Open cited registry record →Leuprolide · 2019-07-24
ClinicalTrials.gov record NCT00669162
Completed at the retained observation.
Open cited registry record →2018
2 recordsGoserelin · 2018-08-07
ClinicalTrials.gov record NCT00283803
Completed at the retained observation.
Open cited registry record →Goserelin · 2018-03-09
ClinicalTrials.gov record NCT01496131
Completed at the retained observation.
Open cited registry record →2017
4 recordsLeuprolide · 2017-06-01
ClinicalTrials.gov record NCT00225420
Completed at the retained observation.
Open cited registry record →Leuprolide · 2017-05-30
ClinicalTrials.gov record NCT01431391
Completed at the retained observation.
Open cited registry record →Leuprolide · 2017-05-24
ClinicalTrials.gov record NCT02107391
Completed at the retained observation.
Open cited registry record →Degarelix · 2017-04-13
ClinicalTrials.gov record NCT02135445
Completed at the retained observation.
Open cited registry record →2016
3 recordsLeuprolide · 2016-12-13
ClinicalTrials.gov record NCT00928434
Completed at the retained observation.
Open cited registry record →Leuprolide · 2016-09-19
ClinicalTrials.gov record NCT01076335
Completed at the retained observation.
Open cited registry record →Leuprolide · 2016-05-25
ClinicalTrials.gov record NCT00943956
Completed at the retained observation.
Open cited registry record →2015
4 recordsTriptorelin · 2015-10-28
ClinicalTrials.gov record NCT02102646
Completed at the retained observation.
Open cited registry record →Leuprolide · 2015-04-28
ClinicalTrials.gov record NCT00500110
Completed at the retained observation.
Open cited registry record →Degarelix · 2015-04-01
ClinicalTrials.gov record NCT00215683
Completed at the retained observation.
Open cited registry record →Leuprolide · 2015-01-29
ClinicalTrials.gov record NCT00631527
Completed at the retained observation.
Open cited registry record →2014
4 recordsDegarelix · 2014-09-03
ClinicalTrials.gov record NCT00801242
Completed at the retained observation.
Open cited registry record →Leuprolide · 2014-05-15
ClinicalTrials.gov record NCT01088529
Completed at the retained observation.
Open cited registry record →Goserelin · 2014-02-04
ClinicalTrials.gov record NCT01250717
Completed at the retained observation.
Open cited registry record →Leuprolide · 2014-01-06
ClinicalTrials.gov record NCT00003124
Completed at the retained observation.
Open cited registry record →2013
6 recordsLeuprolide · 2013-06-24
ClinicalTrials.gov record NCT00003394
Completed at the retained observation.
Open cited registry record →Degarelix · 2013-05-22
ClinicalTrials.gov record NCT01215513
Completed at the retained observation.
Open cited registry record →Degarelix · 2013-03-21
ClinicalTrials.gov record NCT00451958
Completed at the retained observation.
Open cited registry record →Degarelix · 2013-02-12
ClinicalTrials.gov record NCT01071915
Completed at the retained observation.
Open cited registry record →Degarelix · 2013-01-18
ClinicalTrials.gov record NCT00738673
Completed at the retained observation.
Open cited registry record →Degarelix · 2013-01-03
ClinicalTrials.gov record NCT00967018
Completed at the retained observation.
Open cited registry record →2012
3 recordsDegarelix · 2012-12-19
ClinicalTrials.gov record NCT00295750
Completed at the retained observation.
Open cited registry record →Triptorelin · 2012-07-02
ClinicalTrials.gov record NCT00003026
Completed at the retained observation.
Open cited registry record →Leuprolide · 2012-03-19
ClinicalTrials.gov record NCT00653757
Completed at the retained observation.
Open cited registry record →2011
3 recordsDegarelix · 2011-12-19
ClinicalTrials.gov record NCT00116779
Completed at the retained observation.
Open cited registry record →Degarelix · 2011-05-23
ClinicalTrials.gov record NCT00117949
Completed at the retained observation.
Open cited registry record →Degarelix · 2011-03-23
ClinicalTrials.gov record NCT00468286
Completed at the retained observation.
Open cited registry record →2010
3 recordsDegarelix · 2010-12-24
ClinicalTrials.gov record NCT00268892
Completed at the retained observation.
Open cited registry record →Degarelix · 2010-12-10
ClinicalTrials.gov record NCT00116753
Completed at the retained observation.
Open cited registry record →Leuprolide · 2010-11-09
ClinicalTrials.gov record NCT00002881
Completed at the retained observation.
Open cited registry record →- Condition matching is limited to exact labels on retained ClinicalTrials.gov v3 observations; PeptideScanner does not merge related diagnoses or synonyms.
- Coverage is selective and historical, not a complete or continuously current account of the registry or PubMed.
- The brief does not synthesize study outcomes, compare interventions, or make safety, efficacy, diagnosis, or treatment claims.